Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-18T15:07:18.597Z Has data issue: false hasContentIssue false

S11-01 - The Depression Initiative. The Evaluation of the Processes, Costs and Impact of a Depression Breakthrough Collaborative. Quasi-Experimental Trial

Published online by Cambridge University Press:  17 April 2020

G. Franx
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
M. Oud
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
J. Spijker
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
J. Huyser
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
C. Feltz-Cornelis
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
J. de Lange
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
M. Wensing
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles
R. Grol
Affiliation:
Trimbos-Institute, Utrecht, Netherlands Antilles

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In the Netherlands, the Depression Initiative has been launched in 2006 as a nationwide attempt to implement the Multidisciplinary Guideline for Depression and to evaluate its cost effectiveness. An evaluation of the selected strategy to implement the guidelines, a Breakthrough Collaborative, was conducted as a quasi experimental trial. The intervention group consisted of around 530 patients coming from 10 multidisciplinary teams in primary care. The intervention teams received a set of implementation strategies, as part of the Breakthrough Method, developed by the Institute for Healthcare Improvement (www.ihi.org). The aim of the participants in this implementation project was to implement guideline recommendations directed at a reduction of unnecessary antidepressant treatment for patients with mild depression, better use of effective, but minimally invasive treatment options and improved antidepressant and psychotherapeutic treatment for patients with severe symptoms. Monitoring depression severeness was also one of the goals. This guideline derived, stepped care approach was compared to Care As Usual in the primary care setting, as provided in a different study group (NESDA). Outcomes were measured in terms of quality of care provided by the general practitioner (antidepressant prescription rates) and clinical outcomes (BDI, IDS-SR, WHODAS). A process evaluation and simple economic evaluation was part of the study design. In the presentation, preliminary results will be presented.

Type
Implementation of guidelines and integrated care for depression
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.